BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salah E. Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder: Where do we stand? A systematic review. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2019;17:123-36. [DOI: 10.1111/ddg.13691] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Assaf C, Dobos G, Zech IM, Doess A, Hibbe T, Jadasz JJ. Care structure of patients with mycosis fungoides and Sézary syndrome in Germany - Care research based on SHI claims data. J Dtsch Dermatol Ges 2022. [PMID: 35499207 DOI: 10.1111/ddg.14725] [Reference Citation Analysis]
2 Stranzenbach R. How do we treat cutaneous T-cell lymphoma? Ital J Dermatol Venerol 2021;156:534-44. [PMID: 32938164 DOI: 10.23736/S2784-8671.20.06606-7] [Reference Citation Analysis]
3 Dimassi AB, Howlett C, Phua CW. Multifocal CD4+ Primary Cutaneous Small/Medium Lymphoproliferative Disorder Successfully Treated With Low-Dose Oral Methotrexate: A Case Report. Cureus 2020;12:e8534. [PMID: 32665881 DOI: 10.7759/cureus.8534] [Reference Citation Analysis]
4 Assaf C, Dobos G, Zech IM, Doess A, Hibbe T, Jadasz JJ. Versorgungsstruktur der Patienten mit Mycosis fungoides und Sézary-Syndrom in Deutschland - Versorgungsforschung auf Basis von GKV-Routinedaten. J Dtsch Dermatol Ges 2022;20:643-52. [PMID: 35578415 DOI: 10.1111/ddg.14725_g] [Reference Citation Analysis]
5 Kim J, Jeong M, Jun D, Lee M, Shin D, Kim W, Choi H. Primary cutaneous CD4+ small/medium T-cell lymphoma: a case report. Arch Craniofac Surg 2021;22:199-203. [PMID: 34474543 DOI: 10.7181/acfs.2021.00199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Escanilla C, Guavita Falla PM, Cevallos C, Ávalos Jobet N, Bobadilla Bruneau F. Primary cutaneous CD4-positive small/medium T-cell lymphoproliferative disorder: The first-reported Latin-American case with response to doxycycline. Clin Case Rep 2019;7:2405-9. [PMID: 31893069 DOI: 10.1002/ccr3.2454] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Dobos G, de Masson A, Ram-Wolff C, Beylot-Barry M, Pham-Ledard A, Ortonne N, Ingen-Housz-Oro S, Battistella M, d'Incan M, Rouanet J, Franck F, Vignon-Pennamen MD, Franck N, Carlotti A, Boulinguez S, Lamant L, Petrella T, Dalac S, Joly P, Courville P, Rivet J, Dereure O, Amatore F, Taix S, Grange F, Durlach A, Quéreux G, Josselin N, Moulonguet I, Mortier L, Dubois R, Maubec E, Laroche L, Michel L, Templier I, Barete S, Nardin C, Augereau O, Vergier B, Bagot M; French Study Group on Cutaneous Lymphomas (GFELC). Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry. Br J Dermatol 2021;184:1059-67. [PMID: 33131055 DOI: 10.1111/bjd.19644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Shi H, Zhang J, Xiong J, Gan L, Jiang Y, Xu X, Zhang W, Zeng X, Sun J, Chen H. Clinicopathological analysis of primary cutaneous CD4‐positive small/medium pleomorphic T‐cell lymphoproliferative disorder: a retrospective study of 22 patients. Int J Dermatol 2021;60:497-502. [DOI: 10.1111/ijd.15372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]